Recorded: 23 Feb 2012
In science, when I was ready to start my PhD, I was actually not quite sure what I should do again. And I was first considering electrophysiology and then I spent a summer as a volunteer in an institute, in the Max-Planck Institute, where they were studying chromosomes. And just by accident in the library I found Luria's book on general virology and I read it. And I said, “This is what I want to do, now I have to find a place that does virology.” The only place in Germany at that time where you could study virology, and work in virology, was the Max-Planck Institute in Tubigen. So I applied and I was accepted as a graduate student there, and that really set my way and my direction into viruses.
Dr. Peter Vogt, M.D., Ph.D., serves as Member of Scientific Advisory Board of Onconova Therapeutics, Inc. Dr. Vogt is at the Scripps Institute in La Jolla, CA. He is a member of the National Academy of Sciences and a Lasker Award winner. His fundamental studies on oncogenic avian retroviruses led to the identification of oncogenes in human cells. Dr. Vogt is the editor-in-chief of Virology, a scientific journal.
Dr. Peter Vogt intends to continue his work at the Scripps Research Institute. He is currently working to generate small molecule inhibitors that interfere with the spread of cancer as a new therapeutic approach.